TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
SVA

Sinovac Biotech Ltd

Healthcare · Biotechnology

6.50$ +0.0% vs. previous close Closing price · As of: Sep 12, 2026

Statements

Balance Sheet

Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 8,139 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SVA
Line item Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q2 24 Q4 24 Q2 25 Q4 25 Q1 26 Q2 26
15,066 14,115 14,115 14,115 13,725 13,658 12,897 12,337 11,987 8,542 8,542 8,139
13,115 12,126 12,126 11,769 11,831 11,148 10,645 10,377 7,064 7,064 6,624
6,858 4,278 4,278 1,643 1,270 1,072 335 183 488 488 322
11,846 11,313 11,313 11,069 11,223 10,575 5,971
970 609 609 500 451 405 301 307 286 313 266
267 181 181 183 140 154 97 109 94 94 107
338 28 12 13 13 13
46 80 80 74 74 71 184 136 140 140 142
972 1,402 1,402 1,488 1,635 1,390 2,044 5,644 2,145 2,145 1,674
565 1,092 1,092 1,190 1,148 978 1,452 5,001 1,540 1,540 1,091
8.0 11 11 211 82 182 231
334 20 906 820 17 642 12 590 16 16 250
12 11 178 130 164 233 265 233
9,468 8,921 8,921 8,665 8,709 8,649 8,262 4,370 4,439 4,439 4,505
7,623 7,226 7,226 7,240 7,119 7,108 6,838 2,859 2,816 2,816 2,756
114 100 100 114 114 100 72 72 72 72 72

Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?